B8299

N-Butyldeoxynojirimycin

film (dried in situ), ≥98% (TLC)

• Synonim(y): Miglustat, NB-DNJ
• Wzór empiryczny (zapis Hilla): C₁₀H₂₁NO₄
• Numer CAS: 72599-27-0
• Masa cząsteczkowa: 219.28
• UNSPSC Code: 12352200
• PubChem Substance ID: 24892070
• NACRES: NA.32
• MDL number: MFCD00272581

Właściwości

• Nazwa produktu: N-Butyldeoxynojirimycin, film (dried in situ)
• assay: ≥98% (TLC)
• Quality Segment: 200
• form: film (dried in situ)
• solubility: water: 9.80-10.20 mg/mL, clear, colorless
• storage temp.: 2-8°C
• SMILES string: CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO
• InChI: 1S/C10H21NO4/c1-2-3-4-11-5-8(13)10(15)9(14)7(11)6-12/h7-10,12-15H,2-6H2,1H3/t7-,8+,9-,10-/m1/s1
• InChI key: UQRORFVVSGFNRO-UTINFBMNSA-N
• Gene Information: human ... UGCG(7357)

Opis

General description

N-Butyldeoxynojirimycin is an alkylated product of imino sugar deoxynojirimycin.

Application

N-Butyldeoxynojirimycin has been used:

• in the inhibition of glycolipid synthesis in neuroblastoma cells
• in the inhibition the ceramide-specific glycosyltransferase in hepatocytes
• in the inhibition of β-glucosidase (GBA2) using fluorescence- activity assay in human embryonic kidney (HEK293) cells.

Biochem/physiol Actions

α-glucosidase Inhibitor

N-Butyldeoxynojirimycin is an inhibitor of glucosyltransferase and α-glucosidases. N-Butyldeoxynojirimycin, also known as misglustat, reduces glycolipid levels by substrate reduction therapy (SRT) and is effectively used for the treatment of glycosphingolipid lysosomal storage disorder, Gaucher disease.

Ta strona może zawierać tekst przetłumaczony maszynowo.

Informacja o środkach bezpieczeństwa

• Klasa składowania: 11 - Combustible Solids
• WGK: WGK 3
• Temperatura zapłonu (°F): Not applicable
• Temperatura zapłonu (°C): Not applicable
• PPE (środki ochrony indywidualnej): Eyeshields, Gloves, type N95 (US)